These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 8555075)

  • 1. Quantitation of human cytomegalovirus DNA in bone marrow transplant recipients.
    Gerna G; Furione M; Baldanti F; Percivalle E; Comoli P; Locatelli F
    Br J Haematol; 1995 Nov; 91(3):674-83. PubMed ID: 8555075
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human cytomegalovirus immediate-early mRNA detection by nucleic acid sequence-based amplification as a new parameter for preemptive therapy in bone marrow transplant recipients.
    Gerna G; Baldanti F; Lilleri D; Parea M; Alessandrino E; Pagani A; Locatelli F; Middeldorp J; Revello MG
    J Clin Microbiol; 2000 May; 38(5):1845-53. PubMed ID: 10790111
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnostic significance and clinical impact of quantitative assays for diagnosis of human cytomegalovirus infection/disease in immunocompromised patients.
    Gerna G; Percivalle E; Baldanti F; Sarasini A; Zavattoni M; Furione M; Torsellini M; Revello MG
    New Microbiol; 1998 Jul; 21(3):293-308. PubMed ID: 9699213
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human cytomegalovirus (HCMV) infection in paediatric patients given allogeneic bone marrow transplantation: role of early antiviral treatment for HCMV antigenaemia on patients' outcome.
    Locatelli F; Percivalle E; Comoli P; Maccario R; Zecca M; Giorgiani G; De Stefano P; Gerna G
    Br J Haematol; 1994 Sep; 88(1):64-71. PubMed ID: 7803258
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical significance of expression of human cytomegalovirus pp67 late transcript in heart, lung, and bone marrow transplant recipients as determined by nucleic acid sequence-based amplification.
    Gerna G; Baldanti F; Middeldorp JM; Furione M; Zavattoni M; Lilleri D; Revello MG
    J Clin Microbiol; 1999 Apr; 37(4):902-11. PubMed ID: 10074499
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Low correlation of human cytomegalovirus DNA amplification by polymerase chain reaction with cytomegalovirus disease in organ transplant recipients.
    Weber B; Nestler U; Ernst W; Rabenau H; Braner J; Birkenbach A; Scheuermann EH; Schoeppe W; Doerr HW
    J Med Virol; 1994 Jun; 43(2):187-93. PubMed ID: 8083668
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Monitoring of human cytomegalovirus infection in bone marrow and liver transplant recipients by antigenaemia assay and enzyme-linked immunosorbent assay.
    Zhang X; Fan J; Yang MF; Chen XM; Gao HN; Zhao H; Ma WH; Li LJ
    J Int Med Res; 2009; 37(1):31-6. PubMed ID: 19215671
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Early abnormal liver enzyme levels may increase the prevalence of human cytomegalovirus antigenaemia after hematopoietic stem cell transplantation.
    Ye B; Zhao H
    J Int Med Res; 2017 Apr; 45(2):673-679. PubMed ID: 28415934
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Early virus isolation, early structural antigen detection and DNA amplification by the polymerase chain reaction in polymorphonuclear leukocytes from AIDS patients with human cytomegalovirus viraemia.
    Gerna G; Zipeto D; Parea M; Percivalle E; Zavattoni M; Gaballo A; Milanesi G
    Mol Cell Probes; 1991 Oct; 5(5):365-74. PubMed ID: 1665208
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human cytomegalovirus (HCMV) leukodnaemia correlates more closely with clinical symptoms than antigenemia and viremia in heart and heart-lung transplant recipients with primary HCMV infection.
    Gerna G; Zavattoni M; Baldanti F; Sarasini A; Chezzi L; Grossi P; Revello MG
    Transplantation; 1998 May; 65(10):1378-85. PubMed ID: 9625022
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative quantification of human cytomegalovirus DNA in blood of immunocompromised patients by PCR and Murex Hybrid Capture System.
    Baldanti F; Zavattoni M; Sarasini A; Gatti M; Chezzi L; Gerna G
    Clin Diagn Virol; 1997 Aug; 8(2):159-65. PubMed ID: 9316737
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of a quantitative-competitive PCR for quantification of human cytomegalovirus load and comparison with antigenaemia, viraemia and pp67 RNA detection by nucleic acid sequence-based amplification.
    Bergallo M; Costa C; Tarallo S; Daniele R; Merlino C; Segoloni GP; Negro Ponzi A; Cavallo R
    Panminerva Med; 2006 Jun; 48(2):119-27. PubMed ID: 16953149
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of cytomegalovirus DNAaemia versus pp65-antigenaemia cutoff for guiding preemptive therapy in transplant recipients: a randomized study.
    Gerna G; Baldanti F; Torsellini M; Minoli L; Viganò M; Oggionnis T; Rampino T; Castiglioni B; Goglio A; Colledan M; Mammana C; Nozza F; Daniele L;
    Antivir Ther; 2007; 12(1):63-72. PubMed ID: 17503749
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnosis and monitoring of human cytomegalovirus infection in bone marrow transplant recipients by quantitative competitive PCR.
    Ziyaeyan M; Sabahi F; Alborzi A; Mahboudi F; Kazemnejad A; Ramzi M; Moravej A; Jaberi MM
    Exp Clin Transplant; 2006 Jun; 4(1):470-4. PubMed ID: 16827646
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Qualitative detection of human cytomegalovirus DNA in the plasma of bone marrow transplant recipients: value as a predictor of disease progression.
    Behzad-Behbahani A; Ehsanipour F; Alborzi A; Nourani H; Ramzi M; Rasoli M
    Exp Clin Transplant; 2004 Jun; 2(1):196-200. PubMed ID: 15859928
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human herpesvirus-6 and human herpesvirus-7 infections in bone marrow transplant recipients.
    Chan PK; Peiris JS; Yuen KY; Liang RH; Lau YL; Chen FE; Lo SK; Cheung CY; Chan TK; Ng MH
    J Med Virol; 1997 Nov; 53(3):295-305. PubMed ID: 9365899
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinically-based determination of safe DNAemia cutoff levels for preemptive therapy or human cytomegalovirus infections in solid organ and hematopoietic stem cell transplant recipients.
    Lilleri D; Baldanti F; Gatti M; Rovida F; Dossena L; De Grazia S; Torsellini M; Gerna G
    J Med Virol; 2004 Jul; 73(3):412-8. PubMed ID: 15170637
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quantitation of human cytomegalovirus DNA in peripheral blood leukocytes of heart transplant recipients: relationship with pp65 antigenemia and with antiviral therapy.
    Barbui A; Pittaluga F; Donegani E; Bobbio M; di Summa M; Marchiaro G
    Clin Microbiol Infect; 1999 Jan; 5(1):23-31. PubMed ID: 11856209
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The development of a quantitative PCR ELISA to determine HCMV DNAaemia levels in heart, heart/lung and lung transplant recipients.
    Barber L; Egan JJ; Turner AJ; Guiver M; Woodcock AA; Yonan N; Deiraniya AK; Fox AJ
    J Virol Methods; 1999 Sep; 82(1):85-97. PubMed ID: 10507416
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Monitoring human cytomegalovirus viral load in peripheral blood leukocytes of renal transplant recipients by a simple limiting dilution-PCR assay.
    Caballero OL; Costa MC; Trevisan A; Oliveira RM; Viotti EA; Távora ER; Vilaça SS; Sabagga E; De-Paula FJ; Távora PF; Brasileiro-Filho G; Villa LL; Simpson AJ
    Braz J Med Biol Res; 1999 Dec; 32(12):1515-23. PubMed ID: 10585633
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.